For: | Marzio DLHD, Fenkel JM. Complementary and alternative medications in hepatitis C infection. World J Hepatol 2014; 6(1): 9-16 [PMID: 24653790 DOI: 10.4254/wjh.v6.i1.9] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v6/i1/9.htm |
Number | Citing Articles |
1 |
Sara I. Aboras, Mohamed A. Korany, Ahmed F. El‐Yazbi, Marwa A. A. Ragab, Heba H. Abdine. In‐depth investigation of the Silymarin effect on the pharmacokinetic parameters of sofosbuvir, GS‐331007 and ledipasvir in rat plasma using LC–MS. Biomedical Chromatography 2022; 36(9) doi: 10.1002/bmc.5427
|
2 |
Salamat Ali, Shahan Ullah, Vibhu Paudyal, Mashhood Ali, Muhammad Khalid Tipu, Tofeeq Ur-Rehman, Svein Haavik. Complementary and Alternative Medicines for the Treatment of Hepatitis C: Perspectives of Users and CAM Practitioners. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/3932690
|
3 |
Alireza Ebrahimi. Can hepatitis C virus infection be cured with complementary and alternative medicine?. Gastroenterology & Hepatology: Open Access 2021; 12(6): 173 doi: 10.15406/ghoa.2021.12.00481
|
4 |
Shannon Kim, Rishi M. Nadar, Jack DeRuiter, Suhrud Pathak, Sindhu Ramesh, Timothy Moore, Dinesh Chandra Agrawal, Muralikrishnan Dhanasekaran. Mushrooms with Therapeutic Potentials. 2023; : 369 doi: 10.1007/978-981-19-9550-7_13
|
5 |
|
6 |
Sailaja Kesiraju, Praneeth Srikanti, S. Sahariah. Hepatitis C infection in renal transplantation: pathogenesis, current impact and emerging trends. VirusDisease 2017; 28(3): 233 doi: 10.1007/s13337-017-0393-5
|